USPTO trademark

INTRAVASA

AllowedUSPTOWord markClass 1Class 5Class 42Class 44

"INTRAVASA" is a word mark owned by Theaprin Pharmaceuticals, Inc., filed at the USPTO on January 23, 2025. It has been allowed and covers classes 1, 5, 42 and 44.

Get this data via the API
Official USPTO record
INTRAVASA trademark as filed
As filed with the USPTO
Status
Allowed
Since October 6, 2026
Filed
January 23, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99016157
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns INTRAVASA

The owner and representative on file with the office.

Owner

Theaprin Pharmaceuticals, Inc.

Hauppauge, United States

Representative

Constance B. Stefanou

Morgan, Lewis & Bockius LLP

Goods and services

What the mark covers

The products and services INTRAVASA is filed for, grouped by Nice class.

  • Antioxidants for medical purposes, namely, antioxidants for use in the manufacture of pharmaceuticals, antioxidants for use in the manufacture of food supplements

  • Antipyretic, analgesic, and anti-inflammatory preparations; Veterinary preparations, namely, antipyretics, analgesics, anti-inflammatories preparations and antioxidants; Pharmaceutical preparations for the treatment of COVID-19 cytokine storm as adjunctive therapy, acute myocardial infarction, acute thrombotic stroke, Mild to Moderate pain and Moderate to Severe Pain

  • Health and medical information services, namely, providing information to physicians, healthcare professionals and patients on research of pharmaceutical products; Veterinary health and medical information services, namely, providing information to veterinarians, medical professionals and owners on research of pharmaceutical products

  • Health and medical information services, namely, providing information to physicians, healthcare professionals and patients on diagnostic, prophylactic and therapeutic properties of pharmaceutical products; Veterinary health and medical information services, namely, providing information to veterinarians, medical professionals and owners on diagnostic, prophylactic and therapeutic properties of pharmaceutical products

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Teas/email correspondence entered

10 earlier steps on the official record.

FAQ

About INTRAVASA

Who owns the trademark "INTRAVASA"?

The USPTO trademark "INTRAVASA" (application 99016157) is owned by Theaprin Pharmaceuticals, Inc.

What is the status of "INTRAVASA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull INTRAVASA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a64-d9f3-752f-8a03-5885ed321020
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a64-d9f3-752f-8a03-5885ed321020",
  "object": "trademark",
  "mark_text": "INTRAVASA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99016157",
  "filing_date": "2025-01-23",
  "nice_classes": [
    1,
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Theaprin Pharmaceuticals, Inc.",
      "entity_id": null
    }
  ]
}